These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2479066)
21. Role of surfactant in alveolar defence against inhaled particles. Curti PC; Genghini M Respiration; 1989; 55 Suppl 1():60-7. PubMed ID: 2682871 [TBL] [Abstract][Full Text] [Related]
22. Ambroxol and pulmonary toxicity induced by antineoplastic drugs. Luisetti M; Peona V; Salmona M; Pagnoni AM; Villani F; Knerich R; Genghini M; Abbà L; Pozzi E Int J Clin Pharmacol Res; 1986; 6(2):129-36. PubMed ID: 2424848 [TBL] [Abstract][Full Text] [Related]
23. [Effect of ambroxol on surfactant secretion and synthesis in isolated type II alveolar cells]. Wirtz HR Pneumologie; 2000 Jul; 54(7):278-83. PubMed ID: 11008463 [TBL] [Abstract][Full Text] [Related]
24. The role of alveolar macrophages in surfactant turnover. An experimental study with metabolite VIII of bromhexine (Ambroxol). Eckert H; Lux M; Lachmann B Lung; 1983; 161(4):213-8. PubMed ID: 6688451 [No Abstract] [Full Text] [Related]
25. Changes in pulmonary surfactant function and composition in bleomycin-induced pneumonitis and fibrosis. Schmidt R; Ruppert C; Markart P; Lübke N; Ermert L; Weissmann N; Breithecker A; Ermert M; Seeger W; Günther A Toxicol Appl Pharmacol; 2004 Mar; 195(2):218-31. PubMed ID: 14998687 [TBL] [Abstract][Full Text] [Related]
26. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Serrano-Mollar A; Closa D; Prats N; Blesa S; Martinez-Losa M; Cortijo J; Estrela JM; Morcillo EJ; Bulbena O Br J Pharmacol; 2003 Mar; 138(6):1037-48. PubMed ID: 12684259 [TBL] [Abstract][Full Text] [Related]
27. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition. Idell S; James KK; Gillies C; Fair DS; Thrall RS Am J Pathol; 1989 Aug; 135(2):387-99. PubMed ID: 2476934 [TBL] [Abstract][Full Text] [Related]
28. Alterations of the endoalveolar surfactant after surgery with extracorporeal circulation. Marcatili S; Guarino C; Giannattasio A; Marcatili A; Festa M; Cautiero V; Marini MG; Pierfederici P; Dell'Orso S; Cotrufo M Respiration; 1990; 57(4):233-8. PubMed ID: 2095605 [TBL] [Abstract][Full Text] [Related]
29. Protective effect of liposome-entrapped superoxide dismutase and catalase on bleomycin-induced lung injury in rats. II. Phospholipids of the lung surfactant. Ledwozyw A Acta Physiol Hung; 1991; 78(2):157-62. PubMed ID: 1725569 [TBL] [Abstract][Full Text] [Related]
30. Lung injury induced by paraquat, hyperoxia and cobalt chloride: effects of ambroxol. Nemery B; Vanlommel S; Verbeken EK; Lauweryns JM; Demedts M Pulm Pharmacol; 1992; 5(1):53-60. PubMed ID: 1591464 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of bleomycin-induced cell death in rat alveolar macrophages and human lung epithelial cells by ambroxol. Hong JS; Ko HH; Han ES; Lee CS Biochem Pharmacol; 2003 Oct; 66(7):1297-306. PubMed ID: 14505809 [TBL] [Abstract][Full Text] [Related]
32. Phospholipid concentration in lung lavage fluid as biomarker for pulmonary fibrosis. Kuroda K; Morimoto Y; Ogami A; Oyabu T; Nagatomo H; Hirohashi M; Yamato H; Nagafuchi Y; Tanaka I Inhal Toxicol; 2006 May; 18(5):389-93. PubMed ID: 16513595 [TBL] [Abstract][Full Text] [Related]
33. Donor pretreatment with ambroxol or dexamethasone fails to ameliorate reperfusion injury in experimental lung transplantation. Hausen B; Bahra M; Mueller P; Poets CF; Hewitt CW; Morris RE Transpl Int; 1998; 11(3):186-94. PubMed ID: 9638847 [TBL] [Abstract][Full Text] [Related]
34. [The structural changes in the lungs and the phospholipids of the pulmonary surfactant in experimental bleomycin-induced pneumosclerosis in rats]. Loshakova LV; Kirillov IuA; Lebedeva ES; Shul'ga AE; Zlotnikova LA; Alekseevskikh IuG; Danilov LN; Rozenberg OA Biull Eksp Biol Med; 1991 Nov; 112(11):534-6. PubMed ID: 1725757 [TBL] [Abstract][Full Text] [Related]
35. Alveolar derecruitment and collapse induration as crucial mechanisms in lung injury and fibrosis. Lutz D; Gazdhar A; Lopez-Rodriguez E; Ruppert C; Mahavadi P; Günther A; Klepetko W; Bates JH; Smith B; Geiser T; Ochs M; Knudsen L Am J Respir Cell Mol Biol; 2015 Feb; 52(2):232-43. PubMed ID: 25033427 [TBL] [Abstract][Full Text] [Related]
36. [Modulation of alveolar macrophage activity by ambroxol, bromhexine and exogenous arachidonic acid]. Winsel K; Grollmuss H; Unger U; Eckert H Z Erkr Atmungsorgane; 1985; 165(2):149-62. PubMed ID: 3002048 [TBL] [Abstract][Full Text] [Related]
37. [The protective effects of Fufang Biejiafang on bleomycin-induced pulmonary fibrosis in rats]. Kong L; Wang JF; Niu JZ; Xia ZG; Qiao C; Wei YF; Tu HJ Zhongguo Zhong Yao Za Zhi; 2005 Feb; 30(3):204-7. PubMed ID: 15719641 [TBL] [Abstract][Full Text] [Related]
38. Effect of ambroxol on the concentration of cefotaxime in the bronchoalveolar lavage fluid of rats with pulmonary fibrosis. Chen F; Zhang YX; Zhang CQ Exp Ther Med; 2015 Feb; 9(2):539-542. PubMed ID: 25574230 [TBL] [Abstract][Full Text] [Related]
39. [Effects of ambroxol on pulmonary surfactant--analysis of the fatty acid composition of phosphatidylcholine in the sputum and normal respiratory tract fluid in rabbits]. Miyata T; Kai H; Saito M; Okano Y; Takahama K; Nakagawa M; Kojima S Nihon Yakurigaku Zasshi; 1986 Jul; 88(1):57-64. PubMed ID: 3758876 [TBL] [Abstract][Full Text] [Related]
40. [Comparison of the effect of ambroxol and dexamethasone on the expression of pulmonary surfactant proteins in the fetal rat lungs]. Fu XM; Yu JL; Liu GX; Deng B Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):450-3. PubMed ID: 15265434 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]